Cargando…

Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine

Detalles Bibliográficos
Autores principales:	Sabbaghi, Ailar, Malek, Masoud, Abdolahi, Sara, Miri, Seyed Mohammad, Alizadeh, Leila, Samadi, Mehdi, Mohebbi, Seyed Reza, Ghaemi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565071/ https://www.ncbi.nlm.nih.gov/pubmed/34727942 http://dx.doi.org/10.1186/s12985-021-01684-z

Ejemplares similares

A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

Correction to: Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches
por: Sabbaghi, Ailar, et al.
Publicado: (2020)

Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent
por: Samadi, Mehdi, et al.
Publicado: (2022)

Human rotavirus in Iran; molecular epidemiology, genetic diversity and recent updates on vaccine advances
por: Tavakoli Nick, Shadi, et al.
Publicado: (2019)

Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity
por: Kim, Eun-Do, et al.
Publicado: (2015)

Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2022)

Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Correction to: Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Interleukin-21 rs2055979 and Interleukin-21 receptor rs3093390 genetic variants and hepatitis C virus chronic infection
por: Shoraka, Shahrzad, et al.
Publicado: (2017)

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
por: Ghaemi, Amir, et al.
Publicado: (2022)

The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

A gene variation of Interferon Gamma Receptor-I promoter (rs1327474A>G) and chronic hepatitis C virus infection
por: Karkhane, Maryam, et al.
Publicado: (2019)

Analytical Formulation of Ic Dependence on Torsion of YBCO and BSCCO Conductors
por: Fleiter, J, et al.
Publicado: (2013)

The effect of Cinnamaldehyde on mucositis and salivary antioxidant capacity in gamma-irradiated rats (a preliminary study)
por: Molania, Tahereh, et al.
Publicado: (2012)

Zinc oxide nanoparticle reduced biofilm formation and antigen 43 expressions in uropathogenic Escherichia coli
por: Shakerimoghaddam, Ali, et al.
Publicado: (2017)

CCL5 regulation of mucosal chlamydial immunity and infection
por: Sakthivel, Senthilkumar K, et al.
Publicado: (2008)

Mucosal Immunization and Adjuvants
por: Hasegawa, Hideki, et al.
Publicado: (2014)

Host mitochondria: more than an organelle in SARS-CoV-2 infection
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
por: Mahooti, Mehran, et al.
Publicado: (2020)

Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters
por: Kadowaki, Reita, et al.
Publicado: (2023)

SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
por: Shoraka, Shahrzad, et al.
Publicado: (2021)

Correction to: Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection
por: Bardel, Emilie, et al.
Publicado: (2016)

Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012)

The first detection of SARS-CoV-2 RNA in the wastewater of Tehran, Iran
por: Tanhaei, Mohammad, et al.
Publicado: (2021)

An immune cell spray (ICS) formulation allows for the delivery of functional monocyte/macrophages
por: Beneke, Valerie, et al.
Publicado: (2018)

Bladder mucosal autograft: An effective method for repair of vesicovaginal fistula
por: Mohseni, Mohammad G., et al.
Publicado: (2012)

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors
por: Nasioudis, Dimitrios, et al.
Publicado: (2019)

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
por: Di, Shengmeng, et al.
Publicado: (2019)

Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
por: Marques, Rodolfo F., et al.
Publicado: (2022)

Protective Effect of Cornus mas Fruits Extract on Serum Biomarkers in CCl(4)-Induced Hepatotoxicity in Male Rats
por: Alavian, Seyed Moayed, et al.
Publicado: (2014)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Vitamin E ameliorates oral mucositis in gamma-irradiated rats (an in vivo study)
por: Ahmed, Salwa Farid, et al.
Publicado: (2023)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge
por: Patel, Girishchandra B., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_th66lv7va08409mf33m6ppfk7l